News

One ophthalmologist proposes a practice-changing opportunity to eliminate the use of eye drops after cataract surgery.

Understanding these challenges, Ophthalmology Times is retooling its editorial direction, transitioning from a clinical newsmagazine to a resource that will explore the innovative concepts, insights, and discoveries in ophthalmology.

Ocular Therapeutix Inc.’s ReSure Sealant has been declared safe and effective for the management of clear corneal wound leaks following cataract surgery by the FDA’s ophthalmic devices panel.

First Insight Corp. and Kowa Optimed Inc. have announced a joint one-click interface.

An increased risk of cataracts appears to be associated with the use of cholesterol-lowering statins, according to a September report published by JAMA Ophthalmology.

Endonasal dacryocystorhinostomy (DCR) is quickly becoming an attractive procedure among ophthalmologists, according to Nancy Tucker, MD.

Prevent Blindness America (PBA) has launched a new online resource called “Living Well with Low Vision.”

Three pharmaceutical companies have recalled several of their products voluntarily due to sterility concerns and mold.

Almost $3 million has been invested in nine research projects aimed at saving and restoring sight by the Foundation Fight Blindness.

An experimental OCT angiography system can image both surface and deep blood flow at the optical nerve head.

Repeatability of corneal astigmatism measurement was compared using six different devices.

Point source color LED topography has the potential to offer faster and more accurate corneal measurements than existing Placido disc or Scheimpflug imaging technology.

Evaluation of the lamina cribrosa, using a three-dimensional imaging technology and a multi-modal adaptive optics imaging system (Physical Sciences Inc.), allows quantification of the microstructural features.

Early reports are positive for point spread function technology, which is the latest in a long line of attempts to replace the phoropter for refraction.

Highest concavity time may be another important parameter in describing corneal biomechanics as well as a potential risk factor for glaucoma.

Fluidvision accommodating intraocular lens (PowerVision) provides 5 D of accommodation with impressive results.

Phakic IOL implantation is safe and efficacious for treating high myopia and other conditions not amenable to LASIK, with outcomes comparable to those of LASIK and PRK.

There are many differences between adults and children which should be kept in mind when recognizing and treating glaucoma.

The concept of vision à la carte allows all ophthalmic surgeons to design vision for each patient individually, using all of today’s technologies and techniques.

Physicians’ namesake discoveries of various ocular signs provide a historical perspective.

Getting staff behind the benefits of photochromic eyeglass lenses is one of many effective ways to boost sales in the optical dispensary.

Patients with glaucoma undergoing cataract surgery require consideration of a number of factors to ensure optimal outcomes postoperatively.

Sometimes, it is hard to prove what you know to be true is actually true. So, it’s nice to know there is a paper confirming something I have also known to be true: People who lose visual acuity as a result of cataracts will-if they have cataract surgery to restore their vision-live longer than those who do not have surgery.

Alcon Laboratories has announced the global launch of its phacoemulsification technology platform, a vision system designed to provide surgeons with enhanced cataract removal capabilities.

Clarity Medical Systems Inc.’s compact wavefront sensor module has received a patent from the U.S. Patent and Trademark Office.

ThromboGenics NV has entered into a collaboration and license agreement with Bicycle Therapeutics to develop and commercialize drugs inhibiting a specific target for the treatment of diabetic macular edema (DME).